Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Venmax Drugs and Pharmaceuticals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Venmax Drugs and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Venmax Drugs & Pharm - Integrated Filing (Financial)

    14 Feb 2025, 2:50PM Submission of Integrated filing(Financials)for the Quarter and Nine Months ended 31.12.2024 pursuant to SEBI Circular No. SEBI / CFD/CFD-PoD2/CIR/P/20
  • Venmax Drugs & Pharm - Board Meeting Outcome for Financial Results For The Quarter And Nine Months Ended 31.12.2024.

    8 Feb 2025, 3:07PM Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board
  • Venmax Drugs & Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    7 Feb 2025, 4:40PM Pursuant to Regulation 44(3) of SEBI LODR Regulations, 2015, The Scrutinizer report along with Evoting results for the First EGM held on 06.02.2025 is
  • Venmax Drugs & Pharm - Shareholder Meeting / Postal Ballot-Outcome of EGM

    6 Feb 2025, 3:55PM Pursuant to Regulation 30 and Part A of schedule III of SEBI LODR Regulations, 2015, we are submitting the proceedings of EGM held on 6th February 202
  • Venmax Drugs & Pharm - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024.

    3 Feb 2025, 6:06PM Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 ,inter alia,
  • Venmax Drugs & Pharm has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 5:10PM As of December 2024, 23.13% is owned by Indian Promoters and 76.87% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Venmax Drugs & Pharm - Board Meeting Intimation for Increase In Authorised Capital And Fund Raising Proposal.

    6 Jan 2025, 5:14PM Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2025 ,inter alia,
  • Venmax Drugs & Pharm - Announcement under Regulation 30 (LODR)-Cessation

    27 Dec 2024, 1:03PM The Board has considered and accepted the Resignation of Mr. Nooka Krishnaiah from the position of Managing Director and Director of the Company.

Key fundamentals

Evaluate the intrinsic value of Venmax Drugs and Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets -0.298 -0.3624 -0.591 -0.4572 -0.1048
Liabilities -0.298 -0.3624 -0.591 -0.4572 -0.1048
Equity 5.2389 5.2389 5.2389 5.2389 5.2389
Gross Profit -0.1045 -0.1855 -0.1273 -0.3328 -0.2542
Net Profit 0.0645 0.2256 1.8462 -0.1624 -0.2735
Cash From Operating Activities 0.0022 -0.0031 1.905 0.2638 -0.2794
NPM(%) 0 0 0 -96.77 -57.94
Revenue 0 0 0 0.1678 0.4721
Expenses 0.1045 0.1855 0.1273 0.5007 0.7264
ROE(%) -9.92 -34.7 -284 24.99 42.08

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Venmax Drugs and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 13.66 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 49.77 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 103.33 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 46.92 -239.30 0.00

Company Info

Yenkey Drugs and Pharmaceuticals Ltd., was originally incorporated on 28th September, 1988 in the name of Yenkey Medico Drugs Private Limited. The Company has been converted into a public limited company on 3rd Feb'95 in terms of a special resolution passed on 23.01.95 under Section 31(1)/44 of the Companies Act, 1956. Accordingly the Company has obtained a fresh Certificate of Incorporation consequent on the conversion from the Registrar of Companies, Andhra Pradesh vide ref. no. 01-09102 dated 3rd February, 1995. The Company is producing bulk drug intermediates as detailed above and marketing in the domestic markets. The total turnover of the Company is Rs. 89.70 lacs for the year ended March 1994. Now the Company proposes to expand the existing capacity of dye and drug intermediate viz; ECA and diversifying into manufacturing of high value chemicals and bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate. The Company is also proposing to set up a R & D Unit for maintaining high quality control standards of foreign buyers. 2009 -Company has changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd. --Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad - 500 037 to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad - 500 073. 2013 -Venmax Drugs and Pharmaceuticals Ltd has informed that Registered office has been shifted from "Plot No-35,Shivbagh Colony, Ameerpet, Hyderabad - 16" TO "H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad - 32". 2023 -Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka. 2024 - Launched Raaya by atmosphere in Maldives. -Completed the Acquistion transaction pursuant to which our company directly/ indlrectly acquired - Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.

Yenkey Drugs and Pharmaceuticals Ltd., was originally incorporated on 28th September, 1988 in the name of Yenkey Medico Drugs Private Limited. The Company has been converted into a public limited company on 3rd Feb'95 in terms of a special resolution passed on 23.01.95 under Section 31(1)/44 of the Companies Act, 1956. Accordingly the Company has obtained a fresh Certificate of Incorporation consequent on the conversion from the Registrar of Companies, Andhra Pradesh vide ref. no. 01-09102 dated 3rd February, 1995. The Company is producing bulk drug intermediates as detailed above and marketing in the domestic markets. The total turnover of the Company is Rs. 89.70 lacs for the year ended March 1994. Now the Company proposes to expand the existing capacity of dye and drug intermediate viz; ECA and diversifying into manufacturing of high value chemicals and bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate. The Company is also proposing to set up a R & D Unit for maintaining high quality control standards of foreign buyers. 2009 -Company has changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd. --Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad - 500 037 to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad - 500 073. 2013 -Venmax Drugs and Pharmaceuticals Ltd has informed that Registered office has been shifted from "Plot No-35,Shivbagh Colony, Ameerpet, Hyderabad - 16" TO "H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad - 32". 2023 -Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka. 2024 - Launched Raaya by atmosphere in Maldives. -Completed the Acquistion transaction pursuant to which our company directly/ indlrectly acquired - Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.

Read More

Parent Organisation

Venmax Drugs & Pharmaceuticals Ltd.

Founded

28/09/1988

Managing Director

Mr.N Krishnaiah

NSE Symbol

FAQ

The current price of Venmax Drugs and Pharmaceuticals Ltd is

The 52-week high for Venmax Drugs and Pharmaceuticals Ltd is

The market capitalization of Venmax Drugs and Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Venmax Drugs and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Venmax Drugs and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Venmax Drugs and Pharmaceuticals Ltd shares.

The CEO of Venmax Drugs and Pharmaceuticals Ltd is Mr.N Krishnaiah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT